Related Experiment Video

Updated: May 10, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Lumping, splitting, and making sense: implications of soft tissue sarcoma staging for prognosis, therapy, and

Alex B Haynes, Raphael E Pollock

    Annals of Surgical Oncology
    |June 20, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
    09:21

    Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

    Published on: September 13, 2019

    Related Experiment Videos

    Last Updated: May 10, 2026

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

    Published on: July 28, 2020

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
    09:21

    Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

    Published on: September 13, 2019

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Insurance, Race, and Socioeconomic Disparities in Receipt of Surgical Treatment for Melanoma in the United States: A Systematic Review.

    The Journal of surgical research·2026

    Evaluating Variability in Extracellular Vesicle Characterization Across Measurement Techniques.

    Journal of extracellular biology·2026

    Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcoma.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Notch signaling regulates the secretion of pro-metastatic factors in extracellular vesicles in liposarcoma.

    Cancer letters·2026

    Opportunities and Challenges in Using Smartphone Sensor Data to Capture Surgeon Behavior and Well-Being: A Qualitative Analysis of Surgical Residents' Perspectives.

    Journal of surgical education·2026

    Blockade of interleukin-6 (IL-6) signaling in dedifferentiated liposarcoma (DDLPS) decreases mouse double minute 2 (MDM2) oncogenicity via alternative splicing.

    PloS one·2025

    Nodal Zone Count Versus ypN Stage for Predicting First Distant Metastasis After Neoadjuvant Therapy and Esophagectomy in Esophageal Squamous Cell Carcinoma.

    Annals of surgical oncology·2026

    Breast-Conserving Surgery Versus Mastectomy After Neoadjuvant Therapy: A Survival Analysis.

    Annals of surgical oncology·2026

    Prognostic Impact of Lymphovascular Invasion in Resected Pathological Stage I Invasive Non-small Cell Lung Cancer: A Propensity Score-Matched Cohort Study.

    Annals of surgical oncology·2026

    A Percentage of Residual Viable Tumor Outperforms Traditional AJCC Staging in Oral Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy.

    Annals of surgical oncology·2026

    The Efficacy of Adjuvant EGFR-TKI Therapy for Stage IA Lung Adenocarcinoma with EGFR Mutations: A Retrospective Cohort Study.

    Annals of surgical oncology·2026

    ICG Fluorescence-Guided Anatomical Navigation During Robotic Pancreatoduodenectomy: Pancreatic Head Arterial Landmarks and Jejunal Mesenteric Branching.

    Annals of surgical oncology·2026

    AGA Clinical Practice Update on Management of Ampullary Neoplasms: Expert Review.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

    Long-Term Complete Response of Unresectable Small-Cell Neuroendocrine Carcinoma of the Gallbladder following Chemotherapy and Radiotherapy: A Case Report.

    Case reports in oncology·2026

    A Collision Tumour Phenomenon: Dual Metastatic Deposits From Melanoma and Adrenal Carcinoma Causing Small Bowel Intussusception.

    Cureus·2026

    Transcervical Enucleation of a Giant Cervicothoracic Intramural Esophageal Spindle Cell Tumor.

    Annals of thoracic surgery short reports·2026

    Unveiling the Unknown: A Case Report of Undifferentiated Pleomorphic Sarcoma in the Heart.

    Clinical Medicine Insights. Cardiology·2026

    Not All T4 Patients Should Be Considered Equal: Non-Small Cell Lung Cancer Heterogeneity and Surgical Outcome.

    Annals of thoracic surgery short reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us